Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial
Background: The effectiveness of intermittent montelukast for wheeze in young children is unclear. We aimed to assess whether intermittent montelukast is better than placebo for treatment of wheeze in this age group. Because copy numbers of the Sp1-binding motif in the arachidonate 5-lipoxygenase (A...
Main Authors: | Nwokoro, Chinedu (Author), Pandya, Hitesh (Author), Turner, Stephen (Author), Eldridge, Sandra (Author), Griffiths, Christopher J. (Author), Vulliamy, Tom (Author), Price, David (Author), Sanak, Marek (Author), Holloway, John W. (Author), Brugha, Rossa (Author), Koh, Lee (Author), Dickson, Iain (Author), Rutterford, Clare (Author), Grigg, Jonathan (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2014-10.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Parent-determined oral montelukast therapy for preschool wheeze with stratification for arachidonate 5-lipoxygenase (ALOX5) promoter genotype: a multicentre, randomised, placebo-controlled trial
by: Chinedu Nwokoro, et al.
Published: (2015-11-01) -
Is Episodic Short Course of Montelukast Effective in Preschool Wheezing?
by: Prawin Kumar, et al.
Published: (2019-12-01) -
Efficacy of Episodic Use of Montelukast in Preschool Children with Intermittent Wheezing
by: Amita Uday Surana, et al.
Published: (2018-11-01) -
Does 3-day course of oral amoxycillin benefit children of non-severe pneumonia with wheeze: a multicentric randomised controlled trial.
by: Shally Awasthi, et al.
Published: (2008-04-01) -
Montelukast as Add-On Therapy to Inhaled Corticosteroids in the Management of Asthma (The SAS Trial)
by: J Mark FitzGerald, et al.
Published: (2009-01-01)